Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nuwellis, Inc. (NUWE)
USD3.22
+0.00 (+0.00%)
US NASDAQ Healthcare Medical - Devices
Address
12988 Valley View Road 55344
Eden Prairie, MN, US
Eden Prairie, MN, US
CEO
John Erb
Website
nuwellis.com
IPO
2012-02-16
CIK 1506492 ISIN US67113Y8012
Description
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD3.22
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
71.9K
Beta
0.17
Float Shares
881.9K
Free Float %
97.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -4.63% | -14.17% | -47.72% | -57.79% | -40.80% | -97.55% | -99.97% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
3.22
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-65.19
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%-5.4% Q1'26: +26.2% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-217.4% Q1'26: -202.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-261.1% Q1'26: -130.8% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-134.3% Q1'26: -181.6% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-594.9% Q1'26: -1,666.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+420.0% Q1'26: -52.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.03× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
59.0K
est: 180.0K (-67.2%)
|
1.29M
est: 1.80M (-28.4%)
|
3.55M
est: 4.00M (-11.2%)
|
5.00M
est: 5.16M (-3.1%)
|
5.51M
est: 5.80M (-5.0%)
|
7.44M
est: 7.46M (-0.3%)
|
7.92M
est: 8.40M (-5.8%)
|
8.54M
est: 8.41M (+1.6%)
|
8.86M
est: 9.01M (-1.7%)
|
8.74M
est: 8.88M (-1.6%)
|
8.27M
est: 8.16M (+1.4%)
|
9.01M
9.01M – 9.01M
+10.5% YoY
|
10.68M
10.68M – 10.68M
+18.5% YoY
|
35.89M
35.89M – 35.89M
+236.1% YoY
|
49.45M
49.45M – 49.45M
+37.8% YoY
|
| EBITDA |
-25.64M
est: -164.6K (-15,473.2%)
|
-14.65M
est: -1.65M (-789.5%)
|
-10.09M
est: -3.66M (-175.8%)
|
-16.80M
est: -15.26M (-10.1%)
|
-17.87M
est: -5.30M (-236.8%)
|
-16.65M
est: -6.82M (-144.0%)
|
-19.06M
est: -7.69M (-147.9%)
|
-4.90M
est: -17.53M (+72.1%)
|
-16.36M
est: -8.24M (-98.4%)
|
-10.53M
est: -8.12M (-29.6%)
|
-10.69M
est: -7.46M (-43.3%)
|
-8.24M
-8.24M – -8.24M
-10.5% YoY
|
-9.77M
-9.77M – -9.77M
-18.5% YoY
|
-32.83M
-32.83M – -32.83M
-236.1% YoY
|
-45.23M
-45.23M – -45.23M
-37.8% YoY
|
| EBIT |
-25.96M
est: -166.2K (-15,521.9%)
|
-15.34M
est: -1.66M (-823.1%)
|
-10.86M
est: -3.69M (-194.1%)
|
-17.04M
est: -15.48M (-10.0%)
|
-18.11M
est: -5.36M (-238.1%)
|
-17.03M
est: -6.89M (-147.2%)
|
-19.55M
est: -7.76M (-151.9%)
|
-5.27M
est: -17.76M (+70.3%)
|
-16.72M
est: -8.32M (-100.9%)
|
-10.84M
est: -8.20M (-32.2%)
|
-11.11M
est: -7.53M (-47.5%)
|
-8.32M
-8.32M – -8.32M
-10.5% YoY
|
-9.86M
-9.86M – -9.86M
-18.5% YoY
|
-33.14M
-33.14M – -33.14M
-236.1% YoY
|
-45.66M
-45.66M – -45.66M
-37.8% YoY
|
| Net Income |
-26.58M
est: -1,725.85T (+100.0%)
|
-15.79M
est: -36,875.07T (+100.0%)
|
-13.38M
est: -1,130.84T (+100.0%)
|
-17.03M
est: -15.48M (-10.0%)
|
-18.11M
est: -131.70T (+100.0%)
|
-15.84M
est: -1.91T (+100.0%)
|
-19.55M
est: -574.26B (+100.0%)
|
-14.53M
est: -17.10M (+15.0%)
|
-20.21M
est: -846.75M (+97.6%)
|
-11.17M
est: -6.78B (+99.8%)
|
-17.52M
est: -177.51M (+90.1%)
|
-11.66M
-11.66M – -11.66M
+93.4% YoY
|
-6.42M
-6.42M – -6.42M
+45.0% YoY
|
205.80M
205.80M – 205.80M
+3,306.5% YoY
|
411.60M
411.60M – 411.60M
+100.0% YoY
|
| SGA |
8.35M
est: 314.7K (+2,551.6%)
|
8.13M
est: 3.15M (+158.3%)
|
10.17M
est: 6.99M (+45.4%)
|
15.31M
est: 9.01M (+69.8%)
|
16.29M
est: 10.14M (+60.6%)
|
17.42M
est: 13.04M (+33.5%)
|
19.04M
est: 14.69M (+29.6%)
|
17.58M
est: 14.70M (+19.6%)
|
17.19M
est: 14.49M (+18.7%)
|
—
est: 14.27M (-100.0%)
|
13.52M
est: 13.11M (+3.1%)
|
14.48M
14.48M – 14.48M
+10.5% YoY
|
17.16M
17.16M – 17.16M
+18.5% YoY
|
57.68M
57.68M – 57.68M
+236.1% YoY
|
79.48M
79.48M – 79.48M
+37.8% YoY
|
| EPS |
-12,922,937.81
est: -1,300,320,000.00 (+99.0%)
|
-5,264,000.00
est: -27,783,000,064.00 (+100.0%)
|
-4,460,666.67
est: -852,011,968.00 (+99.5%)
|
-4,258,000.00
est: -180,942,304.00 (+97.6%)
|
-411,681.82
est: -99,225,000.00 (+99.6%)
|
-20,276.57
est: -1,439,130.00 (+98.6%)
|
-10,004.09
est: -432,670.00 (+97.7%)
|
-2,921.95
est: -238,213.50 (+98.8%)
|
-360.07
est: -122.69 (-193.5%)
|
-8.00
est: -983.01 (+99.2%)
|
-25.39
est: -25.72 (+1.3%)
|
-1.69
-1.69 – -1.69
+93.4% YoY
|
-0.93
-0.93 – -0.93
+45.0% YoY
|
29.82
29.82 – 29.82
+3,306.5% YoY
|
59.64
59.64 – 59.64
+100.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-10.03M
OE per share TTM
-16.86
Owner's Yield
-611.95%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
18.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
4
Beneficial owners (>5%)
26
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CVI Investments, Inc. | 6.67M | 8.70% | — | — | — | 6.67M | CO | Cayman Islands | 2020-08-25 | ↗ |
| 2 | Heights Capital Management, Inc. | 6.67M | 8.70% | — | — | — | 6.67M | CO | Cayman Islands | 2020-08-25 | ↗ |
| 3 | Jeff Easton | 2.55M | 8.10% | 2.55M | — | 2.55M | — | IN | Delaware | 2022-10-20 | ↗ |
| 4 | Lind Global Fund II LP | 2.55M | 8.10% | 2.55M | — | 2.55M | — | PN | Delaware | 2022-10-20 | ↗ |
| 5 | Lind Global Partners II LLC | 2.55M | 8.10% | 2.55M | — | 2.55M | — | OO | Delaware | 2022-10-20 | ↗ |
| 6 | Empery Asset Master, Ltd. | 1.77M | 9.99% | — | 1.77M | — | — | PN | United States | 2020-02-03 | ↗ |
| 7 | S.H.N. Financial Investments Ltd. | 1.04M | 5.70% | 1.04M | — | — | — | OO | Israel | 2024-05-06 | ↗ |
| 8 | Michael Bigger | 515.0K | 8.50% | — | — | 15.0K | 500.0K | IN | Delaware | 2021-03-23 | ↗ |
| 9 | Empery Asset Management, LP | 479.3K | 4.35% | — | 479.3K | — | — | PN | Delaware | 2022-01-20 | ↗ |
| 10 | Martin D. Hoe | 479.3K | 4.35% | — | 479.3K | — | — | IN | Delaware | 2022-01-20 | ↗ |
| 11 | Ryan M. Lane | 479.3K | 4.35% | — | 479.3K | — | — | IN | Delaware | 2022-01-20 | ↗ |
| 12 | Bigger Capital Fund GP, LLC | 375.0K | 6.20% | — | — | — | 375.0K | OO | Delaware | 2021-03-23 | ↗ |
| 13 | Bigger Capital Fund, LP | 375.0K | 6.20% | — | — | — | 375.0K | PN | Delaware | 2021-03-23 | ↗ |
| 14 | 13G/A | 339.8K | 4.90% | — | 339.8K | — | 339.8K | FI, CO | — | 2020-02-14 | ↗ |
| 15 | District 2 Capital Fund LP | 125.0K | 2.10% | — | — | — | 125.0K | PN | Delaware | 2021-03-23 | ↗ |
| 16 | District 2 Capital LP | 125.0K | 2.10% | — | — | — | 125.0K | PN | Delaware | 2021-03-23 | ↗ |
| 17 | District 2 GP LLC | 125.0K | 2.10% | — | — | — | 125.0K | OO | Delaware | 2021-03-23 | ↗ |
| 18 | District 2 Holdings LLC | 125.0K | 2.10% | — | — | — | 125.0K | OO | Delaware | 2021-03-23 | ↗ |
| 19 | Daniel B. Asher | 98.1K | 4.99% | — | 98.1K | — | 98.1K | HC, IN | United States of America | 2024-08-30 | ↗ |
| 20 | Intracoastal Capital LLC | 98.1K | 4.99% | — | 98.1K | — | 98.1K | OO | United States of America | 2024-08-30 | ↗ |
| 21 | Mitchell P. Kopin | 98.1K | 4.99% | — | 98.1K | — | 98.1K | HC, IN | United States of America | 2024-08-30 | ↗ |
| 22 | Altium Capital Management, LP | 9.5K | 0.30% | — | 9.5K | — | — | IA, PN | Delaware, United States of America | 2021-02-16 | ↗ |
| 23 | Altium Growth Fund, LP | 9.5K | 0.30% | — | 9.5K | — | — | PN | Delaware, United States of America | 2021-02-16 | ↗ |
| 24 | Altium Growth GP, LLC | 9.5K | 0.30% | — | 9.5K | — | — | OO | Delaware, United States of America | 2021-02-16 | ↗ |
| 25 | Hudson Bay Capital Management LP | — | 0.00% | — | — | — | — | PN | State of Delaware | 2022-02-08 | ↗ |
| 26 | Sander Gerber | — | 0.00% | — | — | — | — | IN | United States | 2022-02-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
27.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+26,976
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 6,744 | 1.16 | 7.8K | 6,744 | D | ↗ |
| 2026-04-28 | McDonald David | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 6,744 | 1.16 | 7.8K | 6,744 | D | ↗ |
| 2026-04-28 | Feldshon Archelle Georgiou | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 6,744 | 1.16 | 7.8K | 6,744 | D | ↗ |
| 2026-04-28 | Emerson Martin J | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 6,744 | 1.16 | 7.8K | 6,744 | D | ↗ |
| 2026-02-24 | McDonald David | Director | — | — | Nonstatutory Stock Option | 7 | 1.32 | 9.24 | 0 | D | ↗ |
| 2026-02-24 | Emerson Martin J | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-28 | Schultz Carisa | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-21 | Grasso Mika | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-01-21 | Field Katharyn | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-06-27 | ERB JOHN L | Director / Officer / 10% Owner | A-Award | A | Incentive Stock Option (right to buy) | 115,329 | 0.24 | 27.4K | 115,329 | D | ↗ |
| 2025-06-10 | ERB JOHN L | Director / Officer / 10% Owner | C-Conversion | A | Common Stock | 7,522 | 0.06 | 451.32 | 1,100,022 | D | ↗ |
| 2025-06-09 | ERB JOHN L | Director / Officer / 10% Owner | C-Conversion | A | Common Stock | 1,092,500 | 0.06 | 65.6K | 1,092,500 | D | ↗ |
| 2025-05-20 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 17,496 | 0.96 | 16.7K | 17,496 | D | ↗ |
| 2025-05-20 | McDonald David | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 17,496 | 0.96 | 16.7K | 17,496 | D | ↗ |
| 2025-05-20 | McCormick Michael Kendrick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 17,496 | 0.96 | 16.7K | 17,496 | D | ↗ |
| 2025-05-20 | Feldshon Archelle Georgiou | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 17,496 | 0.96 | 16.7K | 17,496 | D | ↗ |
| 2024-01-02 | McDonald David | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 11,365 | 0.69 | 7.8K | 11,365 | — | ↗ |
| 2024-01-02 | McCormick Michael Kendrick | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 20,836 | 0.69 | 14.4K | 20,836 | — | ↗ |
| 2024-01-02 | Feldshon Archelle Georgiou | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 11,365 | 0.69 | 7.8K | 11,365 | — | ↗ |
| 2023-11-01 | McDonald David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-11-01 | Feldshon Archelle Georgiou | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-02 | Scott Robert Benjamin | Officer | — | D | Incentive Stock Option (right to buy) | 12 | 930.00 | 11.2K | 0 | — | ↗ |
| 2023-06-01 | McCormick Michael Kendrick | Director | A-Award | A | Non-qualified Stock Option (right to buy) | 1,967 | 2.75 | 5.4K | 1,967 | — | ↗ |
| 2023-05-19 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 2,146 | 3.02 | 6.5K | 2,146 | — | ↗ |
| 2023-05-19 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 2,146 | 3.02 | 6.5K | 2,146 | — | ↗ |
| 2023-05-19 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 2,146 | 3.02 | 6.5K | 2,146 | — | ↗ |
| 2023-05-19 | ERB JOHN L | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 2,146 | 3.02 | 6.5K | 2,146 | — | ↗ |
| 2023-03-15 | Jaramillo Nestor Jr. | Director / Officer | P-Purchase | A | Common Stock | 4,098 | 4.79 | 19.6K | 4,098 | — | ↗ |
| 2023-03-03 | Jaramillo Nestor Jr. | Director / Officer | A-Award | A | Non-qualified Stock Option (right to buy) | 13,866 | 7.72 | 107.0K | 13,866 | — | ↗ |
| 2023-03-03 | AYOTTE NEIL P | Officer | A-Award | A | Incentive Stock Option (right to buy) | 8,640 | 7.72 | 66.7K | 8,640 | — | ↗ |
| 2023-01-06 | Blake Lynn Larson | Officer | A-Award | A | Nonstatutory Stock Option (right to buy) | 12,417 | 0.00 | — | 12,417 | — | ↗ |
| 2022-10-19 | Blake Lynn Larson | Officer | — | I | Common Stock | 0 | 0.00 | — | 10,000 | — | ↗ |
| 2022-05-25 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 15,806 | 0.00 | — | 15,806 | — | ↗ |
| 2022-05-25 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 15,806 | 0.00 | — | 15,806 | — | ↗ |
| 2022-05-25 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 15,806 | 0.00 | — | 15,806 | — | ↗ |
| 2022-05-25 | ERB JOHN L | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 15,806 | 0.00 | — | 15,806 | — | ↗ |
| 2022-05-25 | Brandt Steven Frank | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 15,806 | 0.62 | 9.8K | 15,806 | — | ↗ |
| 2022-03-03 | Montague George | Officer | A-Award | A | Incentive Stock Option (right to buy) | 40,054 | 0.00 | — | 40,054 | — | ↗ |
| 2022-03-03 | Jaramillo Nestor Jr. | Officer | A-Award | A | Incentive Stock Option (right to buy) | 101,190 | 0.00 | — | 101,190 | — | ↗ |
| 2022-03-03 | AYOTTE NEIL P | Officer | A-Award | A | Incentive Stock Option (right to buy) | 26,352 | 0.00 | — | 26,352 | — | ↗ |
| 2021-08-18 | ERB JOHN L | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 8,752 | 4.57 | 40.0K | 8,752 | — | ↗ |
| 2021-06-28 | Montague George | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-07 | AYOTTE NEIL P | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-05-19 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 9,798 | 3.63 | 35.6K | 9,798 | — | ↗ |
| 2021-05-19 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 9,798 | 3.63 | 35.6K | 9,798 | — | ↗ |
| 2021-05-19 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 9,798 | 3.63 | 35.6K | 9,798 | — | ↗ |
| 2021-05-19 | ERB JOHN L | Director | A-Award | A | Incentive Stock Option (right to buy) | 75,973 | 3.63 | 275.8K | 75,973 | — | ↗ |
| 2021-05-19 | Brandt Steven Frank | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 9,798 | 3.63 | 35.6K | 9,798 | — | ↗ |
| 2021-01-22 | Wotta Paul | Officer | — | D | Incentive Stock Option | 1,250 | 9.30 | 11.6K | 0 | — | ↗ |
| 2021-01-22 | ERB JOHN L | Director / Officer | A-Award | A | Incentive Stock Option | 33,125 | 9.30 | 308.1K | 33,125 | — | ↗ |
| 2020-05-20 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option | 18,849 | 0.35 | 6.6K | 18,849 | — | ↗ |
| 2020-05-20 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option | 18,849 | 0.35 | 6.6K | 18,849 | — | ↗ |
| 2020-05-20 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option | 18,849 | 0.35 | 6.6K | 18,849 | — | ↗ |
| 2019-09-03 | Costanzo Maria Rosa | Director | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-05-23 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 1,970 | 3.42 | 6.7K | 1,970 | — | ↗ |
| 2019-05-23 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 1,970 | 3.42 | 6.7K | 1,970 | — | ↗ |
| 2019-05-23 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 1,970 | 3.42 | 6.7K | 1,970 | — | ↗ |
| 2019-05-07 | Jaramillo Nestor Jr. | Officer | — | D | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-03-12 | ERB JOHN L | Director / Officer | P-Purchase | A | Series 2 Warrant to Purchase Common Stock (right to buy) | 9,523 | 5.25 | 50.0K | 9,523 | — | ↗ |
| 2018-08-10 | WALLER GREGORY D | Director | S-Sale | D | Common Stock | 72 | 1.03 | 74.43 | 2 | — | ↗ |
| 2018-08-01 | Lynch Thomas P. | Officer | — | D | Non Statutory Stock Option | 9,638 | 14.00 | 134.9K | 0 | — | ↗ |
| 2018-07-03 | ERB JOHN L | — | P-Purchase | A | Common Stock | 23,584 | 2.12 | 50.0K | 29,355 | — | ↗ |
| 2018-05-25 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 10,000 | 3.01 | 30.1K | 10,000 | — | ↗ |
| 2018-05-25 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 10,000 | 3.01 | 30.1K | 10,000 | — | ↗ |
| 2018-05-25 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 10,000 | 3.01 | 30.1K | 10,000 | — | ↗ |
| 2018-01-17 | WATSON WARREN S | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 46,206 | 3.55 | 164.0K | 46,206 | — | ↗ |
| 2018-01-17 | WALLER GREGORY D | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 52,807 | 3.55 | 187.5K | 52,807 | — | ↗ |
| 2018-01-17 | Salveson Jon W | Director | A-Award | A | Nonstatutory Stock Option (right to buy) | 46,206 | 3.55 | 164.0K | 46,206 | — | ↗ |
| 2018-01-17 | ERB JOHN L | Director / Officer | A-Award | A | Incentive Stock Option (right to buy) | 659,193 | 3.55 | 2.34M | 659,193 | — | ↗ |
| 2018-01-03 | Wotta Paul | Officer | — | D | Incentive Stock Option | 71 | 1,470.00 | 104.4K | 0 | — | ↗ |
| 2017-11-22 | ERB JOHN L | Director / Officer | P-Purchase | A | Series F Convertible Preferred Stock | 100 | 4.50 | 450.00 | 100 | — | ↗ |
| 2017-10-12 | Choi Ki Yong | 10% Owner | P-Purchase | A | Common Stock | 30,141 | 0.48 | 14.5K | 1,793,109 | — | ↗ |
| 2017-10-11 | Choi Ki Yong | 10% Owner | P-Purchase | A | Common Stock | 31,504 | 0.56 | 17.6K | 1,762,968 | — | ↗ |
| 2017-09-13 | Choi Ki Yong | 10% Owner | P-Purchase | A | Common Stock | 78,211 | 0.64 | 50.1K | 1,731,464 | — | ↗ |
| 2017-08-10 | Choi Ki Yong | 10% Owner | P-Purchase | A | Common Stock | 13,253 | 0.64 | 8.5K | 1,653,253 | — | ↗ |
| 2017-08-08 | Choi Ki Yong | 10% Owner | P-Purchase | A | Common Stock | 180,000 | 0.78 | 140.4K | 1,640,000 | — | ↗ |
| 2017-06-02 | WATSON WARREN S | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 8,000 | 0.57 | 4.6K | 8,000 | — | ↗ |
| 2017-06-02 | WALLER GREGORY D | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 8,000 | 0.57 | 4.6K | 8,000 | — | ↗ |
| 2017-06-02 | Salveson Jon W | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 8,000 | 0.57 | 4.6K | 8,000 | — | ↗ |
| 2017-04-24 | Breidenstein Jim | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-04-19 | ERB JOHN L | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 1.00 | 100.0K | 115,468 | — | ↗ |
| 2017-04-19 | Choi Ki Yong | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,460,000 | — | ↗ |
| 2017-02-02 | Likens Matthew E. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-02-02 | Brandt Steven Frank | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | ERB JOHN L | Director / Officer | P-Purchase | A | Common Stock | 80,000 | 0.22 | 17.6K | 464,128 | — | ↗ |
| 2016-05-26 | WATSON WARREN S | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 22,632 | 0.71 | 16.1K | 22,632 | — | ↗ |
| 2016-05-26 | WALLER GREGORY D | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 22,632 | 0.71 | 16.1K | 22,632 | — | ↗ |
| 2016-05-26 | Salveson Jon W | Director | A-Award | A | Common Stock | 32,864 | 0.00 | — | 42,492 | — | ↗ |
| 2016-05-26 | BUCKMAN PAUL | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 22,632 | 0.71 | 16.1K | 22,632 | — | ↗ |
| 2016-03-16 | ERB JOHN L | Director / Officer | A-Award | A | Incentive Stock Option (right to buy) | 534,000 | 0.93 | 496.6K | 534,000 | — | ↗ |
| 2016-03-15 | ERB JOHN L | Director / Officer | P-Purchase | A | Common Stock | 8,000 | 0.95 | 7.6K | 25,628 | — | ↗ |
| 2016-03-14 | ERB JOHN L | Director / Officer | P-Purchase | A | Common Stock | 8,000 | 0.86 | 6.9K | 17,628 | — | ↗ |
| 2016-01-04 | Lovett Eric | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-08-11 | BUCKMAN PAUL | Director | P-Purchase | A | Common Stock | 10,000 | 2.55 | 25.5K | 24,012 | — | ↗ |
| 2015-05-21 | WATSON WARREN S | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 3,692 | 4.29 | 15.8K | 3,692 | — | ↗ |
| 2015-05-21 | WALLER GREGORY D | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 3,692 | 4.29 | 15.8K | 3,692 | — | ↗ |
| 2015-05-21 | Salveson Jon W | Director | A-Award | A | Common Stock | 5,439 | 0.00 | — | 9,628 | — | ↗ |
| 2015-05-21 | ERB JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 3,692 | 4.29 | 15.8K | 3,692 | — | ↗ |
| 2015-05-21 | BUCKMAN PAUL | Director | A-Award | A | Common Stock | 5,439 | 0.00 | — | 14,012 | — | ↗ |
| 2015-01-05 | Wade Molly | Officer | — | D | Non-qualified Stock Option | 35,000 | 11.00 | 385.0K | 0 | — | ↗ |
| 2015-01-05 | Drayton Claudia | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-01-01 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 953 | 4.24 | 4.0K | 37,223 | — | ↗ |
| 2014-12-01 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 953 | 4.52 | 4.3K | 38,176 | — | ↗ |
| 2014-11-01 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 953 | 4.85 | 4.6K | 39,129 | — | ↗ |
| 2014-10-09 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 1,906 | 5.52 | 10.5K | 40,082 | — | ↗ |
| 2014-09-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 5.72 | 2.6K | 17,272 | — | ↗ |
| 2014-08-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 4.19 | 1.9K | 17,730 | — | ↗ |
| 2014-07-10 | Brown Brian | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-07-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 5.37 | 2.5K | 18,188 | — | ↗ |
| 2014-06-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 5.00 | 2.3K | 18,646 | — | ↗ |
| 2014-05-29 | WATSON WARREN S | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 2,766 | 5.57 | 15.4K | 2,766 | — | ↗ |
| 2014-05-29 | WALLER GREGORY D | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 2,766 | 5.57 | 15.4K | 2,766 | — | ↗ |
| 2014-05-29 | Salveson Jon W | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 2,766 | 5.57 | 15.4K | 2,766 | — | ↗ |
| 2014-05-29 | ERB JOHN L | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 2,766 | 5.57 | 15.4K | 2,766 | — | ↗ |
| 2014-05-29 | BUCKMAN PAUL | Director | A-Award | A | Non-Qualified Stock Option (right to buy) | 2,766 | 5.57 | 15.4K | 2,766 | — | ↗ |
| 2014-05-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 5.77 | 2.6K | 19,104 | — | ↗ |
| 2014-04-28 | Oleson Kimberly | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-04-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 5.92 | 2.7K | 19,562 | — | ↗ |
| 2014-03-17 | MATHIESEN JEFFREY S | Officer | P-Purchase | A | Common Stock | 2,000 | 6.18 | 12.4K | 20,020 | — | ↗ |
| 2014-03-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 7.96 | 3.6K | 18,020 | — | ↗ |
| 2014-02-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 9.00 | 4.1K | 18,478 | — | ↗ |
| 2014-01-08 | MATHIESEN JEFFREY S | Officer | F-InKind | D | Common Stock | 458 | 10.18 | 4.7K | 24,404 | — | ↗ |
| 2013-12-31 | MATHIESEN JEFFREY S | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-12-31 | BUCKMAN PAUL | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-09-08 | MATHIESEN JEFFREY S | Officer | A-Award | A | Common Stock | 11,868 | 0.00 | — | 23,736 | — | ↗ |
| 2013-08-27 | Verta Patrick | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-03-13 | Salveson Jon W | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2013-01-29 | WATSON WARREN S | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-09-12 | ERB JOHN L | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-292.3K
Shares Outstanding
902.7K
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | President and Chief Executive Officer | 341.4K | — | — | 24.9K | — | 8.9K | 375.2K | 6.64% | ↗ |
| 2 | 2025 | Senior Vice President, General Counsel, Secretary & Chief Compliance Officer | 339.5K | — | — | — | — | 11.4K | 350.9K | 0.00% | ↗ |
| 3 | 2025 | Former President & Chief Executive Officer | 111.6K | — | — | — | — | 224.6K | 336.2K | 0.00% | ↗ |
| 4 | 2025 | Former Chief Financial Officer | 252.6K | — | — | — | — | 8.7K | 261.3K | 0.00% | ↗ |
| 5 | 2024 | President Chief Executive Officer | 349.7K | — | — | — | — | 59.7K | 409.4K | 0.00% | ↗ |
| 6 | 2024 | Senior Vice President, General Counsel, Secretary Chief Compliance Officer | 271.4K | — | — | — | 25.6K | 9.9K | 307.0K | 0.00% | ↗ |
| 7 | 2024 | Chief Financial Officer | 245.0K | — | — | — | 20.6K | 4.4K | 270.0K | 0.00% | ↗ |
| 8 | 2023 | President Chief Executive Officer | 420.6K | — | — | 168.9K | — | 17.1K | 606.6K | 27.84% | ↗ |
| 9 | 2023 | General Counsel Chief Compliance Officer | 326.5K | — | — | 63.9K | — | 16.1K | 406.5K | 15.73% | ↗ |
| 10 | 2023 | Lynn L. Blake Former Chief Financial Officer | 248.7K | — | — | 100.0K | — | 11.0K | 359.7K | 27.80% | ↗ |
| 11 | 2023 | Robert B. Scott Chief Financial Officer | 243.2K | — | — | 38.8K | — | 9.4K | 291.4K | 13.32% | ↗ |
| 12 | 2022 | Nestor Jaramillo, Jr. President Chief Executive Officer | 412.3K | — | — | 86.2K | 199.1K | 17.0K | 714.7K | 12.07% | ↗ |
| 13 | 2022 | Neil P. Ayotte SVP, General Counsel Chief Compliance Officer | 289.8K | — | — | 22.4K | 92.2K | 9.1K | 413.6K | 5.42% | ↗ |
| 14 | 2022 | George Montague Former Chief Financial Officer | 273.4K | — | — | — | — | 9.2K | 282.6K | 0.00% | ↗ |
| 15 | 2022 | Lynn L. Blake Chief Financial Officer | 65.4K | — | — | — | 26.7K | 642.00 | 92.8K | 0.00% | ↗ |
| 16 | 2020 | John L. Erb Chairman of the Board | 453.4K | — | — | — | 202.6K | 8.8K | 664.8K | 0.00% | ↗ |
| 17 | 2020 | Nestor Jaramillo, Jr. President Chief Executive Officer | 343.3K | — | — | — | 127.0K | 10.9K | 481.1K | 0.00% | ↗ |
| 18 | 2020 | Claudia Drayton Chief Financial Officer | 308.3K | — | — | — | 111.7K | 13.1K | 433.0K | 0.00% | ↗ |
| 19 | 2019 | John L. Erb Chairman of the Board | 437.0K | — | — | — | 131.1K | 11.7K | 579.8K | 0.00% | ↗ |
| 20 | 2019 | Nestor Jaramillo, Jr. President Chief Executive Officer | 208.7K | — | — | 254.2K | 57.4K | 6.6K | 526.7K | 48.26% | ↗ |
| 21 | 2019 | Claudia Drayton Chief Financial Officer | 291.7K | — | — | — | 81.7K | 19.0K | 392.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Neil Ayotte | Senior Vice President, General Counsel, Secretary & Chief Compliance Officer | 350.9K | male |
| John L. Erb | CEO, President & Chairman | 350.3K | male |
| David Lerner | Chief Technology Officer | — | male |
| Kim Anderson | Vice President of Operations | — | female |
| Leah McMullen | Director of Communications | — | — |
| Betsy Riemenschneider | Vice President of Sales | — | — |
| Paul Wotta | Corporate Controller | — | male |
| Carisa Schultz | CFO, Principal Financial Officer & Principal Accounting Officer | — | female |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NUWE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
